Breast Cancer

Better prognosis for HRT users more likely due to frequent screening

Published in Women's Health Weekly, December 25th, 2003

While women with breast cancer who have used hormone replacement therapy (HRT) are known to have better survival odds than those who've never taken hormones, the advantage is due, most likely, to more frequent mammography screening rather than the effect of the hormones on tumor biology, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

"Most of the good prognostic factors that have been ascribed to HRT - such as smaller tumor size and earlier cancer stage at diagnosis - may simply be an artifact of screening," said Janet Daling, PhD, lead author of the paper, which appeared in the November 2003 issue of Cancer Epidemiology,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-12-25)

View Other Issues of Women's Health Weekly

View Other NewsRx Publications

More Articles from Women's Health Weekly

Gynecology
Instrumental vaginal deliveries are not likely to cause anorectal symptoms

Lung Cancer
Female smokers are twice as likely as male smokers to develop deadly disease

Anorexia Nervosa
Physical activity attenuates bone loss in those with eating disorders

Gynecology
Pelvic floor training improves some aspects of sexual function

Menopause
Parathyroid hormone increases bone mineral density in osteoporotic women

Menstrual Suppression
New survey reveals stark differences between clinicians and women on concept

More from this issue of Women's Health Weekly

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Top Medical Newsletters

Vaccine Weekly

AIDS Weekly

Blood Weekly

Cancer Weekly

Hepatitis Weekly

TB & Outbreaks Week

Women's Health Weekly

Medical Letter on the CDC & FDA

Gene Therapy Weekly

Obesity & Diabetes Week

More Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications

Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database

Breast Cancer

Better prognosis for HRT users more likely due to frequent screening

More Articles from Women's Health Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Facts & Stats